700 arthritis patients to reveal Real-World drug performance
NCT ID NCT07166315
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 24 times
Summary
This study follows 700 adults with axial spondyloarthritis or psoriatic arthritis who have just started a new medication (bimekizumab, upadacitinib, risankizumab, guselkumab, or a TNF inhibitor) at UK hospitals. Researchers will review medical records and ask patients to complete surveys about their symptoms and treatment experience. The goal is to see how well these drugs control disease activity from both the doctor's and patient's perspective in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS (PSA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal National Hospital for Rheumatic Diseases
RECRUITINGBath, Somerset, BA1 3NG, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.